1-9 of 9
Mark Schroeder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Kinetics of circulating multiple myeloma cells (CMMCs) in patients undergoing standard-of-care anti-BCMA chimeric antigen receptor T cell therapy for Relapsed/Refractory multiple myeloma

Free
Michael Slade, Julie Fortier, Mark Fiala, Binod Dhakal, Hans Lee, Frank Kuhr, Wojciech Swat, Paola Tononi, Nicolo Manaresi, Alberto Ferrarini, Sarah Kelley, Mark Schroeder, Keith Stockerl-Goldstein, Ravi Vij
Journal: Blood
Blood (2025) 146 (Supplement 1): 5851.
https://doi.org/10.1182/blood-2025-5851
Published: 2025
Journal Articles

Impact of race and social deprivation on outcomes with modern day induction therapy in patients with newly diagnosed multiple myeloma: An ASH research collaborative data hub analysis

Free
Hamza Hashmi, Meera Mohan, Susan Geyer, Levi Pederson, Peyton Schumacher, Paul Gater, Shandra James, Emily Semmel, Travis Cleaves, Aaron Rosenberg, Samuel Rubinstein, Anita D'Souza, Joselle Cook, Mark Schroeder, Adam Sperling, Jeffrey Zonder, Ajay Nooka, Thomas Martin, Manisha Bhutani, Shambavi Richard, Saad Usmani
Journal: Blood
Blood (2025) 146 (Supplement 1): 2237.
https://doi.org/10.1182/blood-2025-2237
Published: 2025
Journal Articles

Pilot study of cell-free DNA (cfDNA) for measurable residual disease monitoring following autologous hematopoietic cell transplant in multiple myeloma

Free
Yamuna Kondapally, Julie Fortier, Antony Tin, Sarah Kelley, Derrick Renner, Mark Fiala, Angel Rodriguez, Minetta Liu, Mark Schroeder, Keith Stockerl-Goldstein, Ravi Vij, Michael Slade
Journal: Blood
Blood (2025) 146 (Supplement 1): 2219.
https://doi.org/10.1182/blood-2025-2219
Published: 2025
Journal Articles

Feasibility of risk classification with newly proposed international myeloma working group (IMWG) high-risk definition: A single-center analysis using natural language processing

Free
Michael Slade, Mark Fiala, Julie Fortier, Sarah Kelley, David Spencer, Mark Schroeder, Keith Stockerl-Goldstein, Ravi Vij
Journal: Blood
Blood (2025) 146 (Supplement 1): 2218.
https://doi.org/10.1182/blood-2025-2218
Published: 2025
Journal Articles

Motixafortide + G-CSF hematopoietic stem cell mobilization in patients with multiple myeloma following quadruplet induction therapy

Free
Zachary Crees, Mark Schroeder, Michael Slade, Keith Stockerl-Goldstein, Ravi Vij, Ella Sorani, Irit Glicko-Kabir, Michael Rettig, John DiPersio
Journal: Blood
Blood (2025) 146 (Supplement 1): 5957.
https://doi.org/10.1182/blood-2025-5957
Published: 2025
Journal Articles

Defining functional high-risk multiple myeloma in the era of modern induction therapy

Free
Barry Paul, Carlyn Tan, Susan Geyer, Levi Pederson, Peyton Schumacher, C. Kennedy, Emily Semmel, Shandra James, Travis Cleaves, Saurabh Zanwar, Mark Schroeder, Jeffrey Zonder, Thomas Martin, Ajay Nooka, Anita D'Souza, Shambavi Richard, Adam Sperling, Aaron Rosenberg, Samuel Rubinstein, Saad Usmani, Hamza Hashmi, Manisha Bhutani
Journal: Blood
Blood (2025) 146 (Supplement 1): 4014.
https://doi.org/10.1182/blood-2025-4014
Published: 2025
Journal Articles

Molecular profiling and kinetics of circulating multiple myeloma cells (CMMCs) predict resistance to bispecific antibodies (BsAbs) in relapsed and/or refractory multiple myeloma (RRMM)

Free
Binod Dhakal, Michael Slade, Mostafa Mohamed, Mark Schroeder, Ravi Kishore Narra, Othman Akhtar, Hima Bansal, Maria Acevedo-Calado, Oren Pasvolsky, Mahmoud Gaballa, Melody Becnel, Donna Weber, Krina Patel, Sheeba Thomas, Jing Christine Ye, Meera Mohan, Marcelo Pasquini, Fumou Sun, Keith Stockerl-Goldstein, Anita D'Souza, Ravi Vij, Maher Albitar, Robert Orlowski, Hans Lee
Journal: Blood
Blood (2025) 146 (Supplement 1): 4012.
https://doi.org/10.1182/blood-2025-4012
Published: 2025
Journal Articles

Efficacy and safety of frail adults treated with ciltacabtagene autoleucel in the real-world: A CIBMTR analysis

Free
Hira Mian, Muhammad Salman Faisal, Tiening Chen, Ruta Brazauskas, Temitope Oloyede, Nausheen Ahmed, Aimaz Afrough, Larry Anderson, Rahul Banerjee, Jesús Berdeja, Aram Bidikian, Jakob Devos, Binod Dhakal, Ajoy Dias, Danai Dima, Yvonne Efebera, Lohith Gowda, Doris Hansen, Hamza Hashmi, Heather Landau, Lazaros Lekakis, Abu-Sayeef Mirza, Ravi Narra, Krina Patel, Ashley Rosko, Mark Schroeder, Surbhi Sidana, Saad Usmani, Marcelo Pasquini, Othman Akhtar, Taiga Nishihori, Meera Mohan
Journal: Blood
Blood (2025) 146 (Supplement 1): 133.
https://doi.org/10.1182/blood-2025-133
Published: 2025
Journal Articles

An open-label phase I study of JAK inhibitor ruxolitinib with and without CTLA-4 ig abatacept for the prophylaxis of graft-versus-host ddsease and cytokine release syndrome after T-cell replete haploidentical peripheral blood hematopoietic cell transplantation

Free
Ramzi Abboud, Feng Gao, Maggie Nash, Jeffrey King, Samantha Bauer, Camille Abboud, Zachary Crees, Meagan Jacoby, Iskra Pusic, Mark Schroeder, Samuel Urrutia, Geoffrey Uy, John DiPersio
Journal: Blood
Blood (2025) 146 (Supplement 1): 2459.
https://doi.org/10.1182/blood-2025-2459
Published: 2025